Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Vincetoxicum Hirundinaria Leaf is a clinical substance classified as a Non-Standardized Food Allergenic Extract [EPC], primarily utilized in the diagnostic assessment and immunotherapeutic management of specific environmental and botanical sensitivities.
Name
Vincetoxicum Hirundinaria Leaf
Raw Name
VINCETOXICUM HIRUNDINARIA LEAF
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Vincetoxicum Hirundinaria Leaf
Vincetoxicum Hirundinaria Leaf is a clinical substance classified as a Non-Standardized Food Allergenic Extract [EPC], primarily utilized in the diagnostic assessment and immunotherapeutic management of specific environmental and botanical sensitivities.
Detailed information about Vincetoxicum Hirundinaria Leaf
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Vincetoxicum Hirundinaria Leaf.
Vincetoxicum Hirundinaria Leaf, derived from the White Swallow-wort plant, is a botanical substance utilized in clinical immunology and allergology. It is pharmacologically classified as a Non-Standardized Food Allergenic Extract [EPC]. Unlike standardized extracts, which have a defined potency measured by specific bioassays or international units, non-standardized extracts like Vincetoxicum Hirundinaria Leaf are prepared according to established manufacturing processes but do not have a federally mandated potency standard relative to a reference serum.
This substance belongs to a class of drugs called allergenic extracts, which are used primarily for the diagnosis and treatment of type I immediate hypersensitivity reactions. In the context of clinical practice, your healthcare provider may use this extract to identify specific IgE-mediated sensitivities through skin testing or to induce desensitization through allergen immunotherapy (AIT). The FDA has historically regulated these extracts under the Center for Biologics Evaluation and Research (CBER), ensuring that the raw materials—in this case, the leaves of the Vincetoxicum hirundinaria—are harvested and processed to maintain the integrity of the allergenic proteins.
The mechanism of action for Vincetoxicum Hirundinaria Leaf is rooted in the modulation of the human immune system. At the molecular level, the extract contains various proteins and glycoproteins that act as antigens. When introduced to a sensitized individual, these antigens cross-link specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells and basophils.
In a diagnostic setting (skin testing), this cross-linking triggers the release of inflammatory mediators such as histamine, leukotrienes, and prostaglandins, resulting in a visible 'wheal and flare' reaction. This allows the clinician to confirm the presence of specific sensitization. In a therapeutic setting (immunotherapy), the repeated, incremental administration of the extract works to shift the immune response from a Th2-dominated profile (associated with allergy) to a Th1-dominated or regulatory T-cell (Treg) profile. This process involves the induction of 'blocking antibodies' (IgG4), which compete with IgE for allergen binding, and the suppression of inflammatory cytokines like IL-4 and IL-5. Over time, this raises the patient's threshold for allergic symptoms, providing long-term relief from botanical sensitivities.
As a biological allergenic extract consisting of complex proteins, the traditional pharmacokinetic parameters (ADME) differ significantly from small-molecule drugs.
According to clinical practice guidelines, Vincetoxicum Hirundinaria Leaf is utilized for:
Vincetoxicum Hirundinaria Leaf is generally available in the following forms:
> Important: Only your healthcare provider can determine if Vincetoxicum Hirundinaria Leaf is right for your specific condition. The use of allergenic extracts requires specialized training in the management of anaphylaxis.
Dosage for Vincetoxicum Hirundinaria Leaf is highly individualized and must be determined by an allergist or immunologist based on the patient's sensitivity levels.
Vincetoxicum Hirundinaria Leaf is not specifically FDA-approved for pediatric use in all jurisdictions, but it is frequently used by pediatric allergists. Dosing in children follows the same escalation principle as in adults but may require more conservative increments. Healthcare providers must weigh the risk of systemic reactions against the benefit of long-term allergy resolution. It is generally not recommended for children under the age of 5 due to the difficulty of communicating early symptoms of systemic reactions.
No specific dosage adjustments are required for patients with renal impairment, as the proteins are not cleared by the kidneys in a manner that leads to toxicity. However, the patient's overall health should be stable.
No dosage adjustments are necessary for hepatic impairment. The metabolic breakdown of proteins is independent of primary liver CYP450 enzyme systems.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The risk of using epinephrine (the treatment for a severe reaction) must be considered, as epinephrine can strain the heart in older adults.
This medication is administered exclusively by healthcare professionals in a clinical setting.
If a dose is missed during the build-up phase, the next dose may need to be reduced to ensure safety. If a dose is missed during the maintenance phase by more than 2 weeks, your doctor may 'back-step' the dose to a previous level before resuming the maintenance schedule. Never attempt to double the dose to catch up.
An overdose of Vincetoxicum Hirundinaria Leaf (receiving too much of the extract at once) significantly increases the risk of a systemic allergic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. The schedule is designed to keep your immune system in a state of tolerance.
The most frequent side effects associated with Vincetoxicum Hirundinaria Leaf occur at the site of administration. These are known as local reactions.
> Warning: Stop taking Vincetoxicum Hirundinaria Leaf and call your doctor immediately if you experience any of these symptoms of a systemic reaction.
There is no evidence that long-term use of Vincetoxicum Hirundinaria Leaf causes organ damage or cancer. The primary long-term effect is the desired 'immunological memory,' where the body no longer reacts to the allergen. However, prolonged use of any injectable can occasionally lead to localized skin thickening or scarring (lipohypertrophy) if the injection sites are not properly rotated.
While specific 'Black Box' labels vary by manufacturer, all allergenic extracts carry a standardized warning regarding Anaphylaxis.
Summary of Warning: Vincetoxicum Hirundinaria Leaf can cause severe, life-threatening systemic allergic reactions, including anaphylaxis. Patients with unstable asthma are at a higher risk for fatal outcomes. This product must only be administered in a setting where emergency equipment and personnel trained in treating anaphylaxis are immediately available. Patients must be observed for at least 30 minutes post-injection. Patients should be prescribed and trained in the use of an epinephrine auto-injector for use in case of a delayed reaction.
Report any unusual symptoms to your healthcare provider. Even a mild systemic reaction (like generalized itching) should be reported, as it may predict a more severe reaction with the next dose.
Vincetoxicum Hirundinaria Leaf is intended for use only by clinicians experienced in the diagnosis and treatment of allergic diseases. It is not for self-administration unless specifically authorized under a sublingual protocol, and even then, the first dose must be supervised. Patients must be in a state of relatively good health at the time of injection; having an active infection or a fever may increase the risk of an adverse reaction.
No FDA black box warnings specifically for 'Vincetoxicum Hirundinaria Leaf' exist as a unique entity, but it falls under the General Class Warning for Allergenic Extracts. This warning emphasizes that these products can cause severe systemic reactions and should not be used in patients with severe, unstable, or steroid-dependent asthma. The risk of death from anaphylaxis is increased in patients with compromised respiratory function.
While Vincetoxicum Hirundinaria Leaf does not cause drowsiness directly, a systemic reaction or the administration of antihistamines to treat a local reaction can impair your ability to drive. Use caution until you know how you react to each dose.
Alcohol consumption should be avoided on the day of treatment. Alcohol can cause vasodilation (widening of blood vessels), which may increase the rate of allergen absorption and potentially worsen the severity of an allergic reaction.
Stopping treatment abruptly will result in the gradual loss of the built-up tolerance. If you must stop treatment due to a severe reaction, your doctor will perform a thorough risk-benefit analysis before restarting at a much lower dose.
> Important: Discuss all your medical conditions with your healthcare provider before starting Vincetoxicum Hirundinaria Leaf. Inform them if you are taking beta-blockers, as these can make an allergic reaction harder to treat.
There are no direct interactions between Vincetoxicum Hirundinaria Leaf and specific foods like dairy or grapefruit. However, if you have a known food allergy, consuming that food near the time of your injection may 'prime' your mast cells, making a reaction to the injection more likely.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is vital for your safety during immunotherapy.
Patients sensitive to Vincetoxicum hirundinaria may show cross-reactivity with other members of the Apocynaceae (Dogbane) family, including Asclepias (Milkweed) and Vinca (Periwinkle). If you are allergic to one, your doctor will exercise extra caution when testing or treating you with related botanical extracts.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Vincetoxicum Hirundinaria Leaf. Be honest about your respiratory health and any heart conditions.
Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.
It is not known whether the allergenic proteins or their metabolites are excreted in human milk. However, since these are large proteins that are digested in the infant's gut, the risk to the nursing infant is considered very low. The primary concern remains the mother's risk of a systemic reaction.
Safety and effectiveness in children under the age of 5 have not been established. In older children, the treatment is generally effective, but the healthcare provider must ensure the child is able to cooperate with the observation period and describe early symptoms of a reaction (e.g., 'itchy throat' or 'funny feeling').
Clinical studies of allergenic extracts did not always include sufficient numbers of subjects aged 65 and over. Geriatric patients are more likely to have co-morbidities like hypertension or coronary artery disease, which increases the risk associated with both the allergen and the epinephrine used for emergency treatment.
No dosage adjustment is required. The proteins in the extract are not cleared by the kidneys in their active form; they are broken down into constituent amino acids by systemic proteases.
No dosage adjustment is required. Hepatic function does not significantly impact the clearance or the immunological effect of allergenic extracts.
> Important: Special populations require individualized medical assessment. Always inform your allergist if your health status changes, such as becoming pregnant or starting new heart medications.
Vincetoxicum Hirundinaria Leaf acts as an exogenous antigen. Its primary molecular targets are the IgE receptors (FcεRI) on mast cells and basophils (for diagnosis) and the T-cell receptors (TCR) on naive T-lymphocytes (for therapy).
During immunotherapy, the extract induces the production of Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β) from regulatory T-cells. These cytokines suppress the Th2-mediated allergic inflammation. Furthermore, there is a significant increase in Allergen-specific IgG4, which acts as a 'blocking antibody' to prevent IgE-mediated mast cell degranulation.
The dose-response relationship in immunotherapy is characterized by a slow shift in the immune threshold. The time to onset for diagnostic skin testing is 15-20 minutes. For therapeutic effects, the onset is typically 3-6 months (reaching maintenance), with maximum efficacy often seen after 12-24 months of continuous treatment. Tolerance can persist for several years after the discontinuation of a 3-to-5-year course.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | Primarily to IgE and IgG4 antibodies |
| Half-life | Varies (Proteins degraded within hours/days) |
| Tmax | 1-2 hours (for systemic absorption) |
| Metabolism | Proteolytic degradation |
| Excretion | Cellular catabolism |
Vincetoxicum Hirundinaria Leaf is part of the Allergenic Extracts class. It is specifically categorized as a Non-Standardized Food Allergenic Extract [EPC], though in clinical practice, it is often grouped with other weed or botanical pollens and extracts used in immunotherapy.
Common questions about Vincetoxicum Hirundinaria Leaf
Vincetoxicum Hirundinaria Leaf is primarily used as a diagnostic tool and a therapeutic agent in the field of allergy and immunology. Clinicians use it in skin prick testing to identify if a patient has a specific allergy to the White Swallow-wort plant. If an allergy is confirmed and symptoms are severe, the extract is used in allergen immunotherapy, also known as allergy shots. This process involves giving gradually increasing doses of the extract to desensitize the patient's immune system. The goal is to reduce the severity of allergic reactions upon future environmental exposure.
The most common side effects are localized to the site where the extract was injected or applied. Patients frequently experience redness, itching, and a small amount of swelling at the injection site, which usually resolves within a day. Some people may also experience a 'late-phase' local reaction, where the swelling appears several hours later. Systemic side effects, though less common, can include sneezing, nasal congestion, or a mild headache. Because it is an allergen, there is always a small risk of a more serious reaction, which is why medical supervision is required.
It is generally advised to avoid alcohol on the days you receive an injection of Vincetoxicum Hirundinaria Leaf. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of the allergen into your bloodstream, potentially increasing the risk of a systemic reaction. Additionally, alcohol can sometimes mask the early symptoms of an allergic reaction or make them more difficult to manage. To ensure the highest level of safety during your immunotherapy build-up, it is best to remain sober for at least 24 hours around your appointment. Always consult your allergist for their specific policy on alcohol use.
Vincetoxicum Hirundinaria Leaf is classified as Pregnancy Category C, meaning there is limited data on its safety in human pregnancy. Most allergists recommend against starting a new course of immunotherapy while pregnant because of the risk of anaphylaxis, which can be dangerous for the fetus. However, if you are already on a stable maintenance dose and become pregnant, your doctor may allow you to continue the treatment at that same dose. The primary goal is to avoid any systemic reactions during gestation. Always inform your healthcare provider immediately if you become pregnant while receiving these injections.
The timeline for seeing results from Vincetoxicum Hirundinaria Leaf immunotherapy is relatively long compared to standard medications. While a diagnostic skin test works within 20 minutes, the therapeutic benefits of desensitization usually take several months to become noticeable. Most patients begin to feel an improvement in their allergy symptoms once they reach their maintenance dose, which typically takes 3 to 6 months of weekly injections. Significant and long-lasting relief usually requires consistent treatment for 1 to 2 years. A full course of therapy often lasts 3 to 5 years to ensure the immune system remains desensitized.
Yes, you can stop the injections at any time without experiencing traditional withdrawal symptoms like those seen with certain pills. However, stopping the treatment before the recommended 3-to-5-year period usually means that your allergy symptoms will eventually return. The 'tolerance' built up by your immune system requires consistent exposure to the allergen to become permanent. If you miss several doses, you cannot simply resume at the previous level; your doctor will need to lower the dose and gradually build it back up to ensure safety. Always discuss your reasons for wanting to stop with your allergist first.
If you miss a scheduled injection of Vincetoxicum Hirundinaria Leaf, you should contact your allergist's office as soon as possible to reschedule. Do not try to make up for the missed dose by taking a higher dose later. Depending on how many weeks have passed since your last injection, your doctor may need to reduce the dose for your next visit to prevent a reaction. Safety protocols for missed doses are very strict in immunotherapy to ensure your immune system isn't overwhelmed. Following the prescribed schedule is the best way to ensure the treatment is both safe and effective.
There is no clinical evidence to suggest that Vincetoxicum Hirundinaria Leaf causes weight gain. The extract consists of proteins and glycoproteins that act on the immune system and do not interfere with metabolic rate, insulin sensitivity, or appetite regulation. Unlike oral corticosteroids, which are sometimes used to treat severe allergies and can cause weight gain, allergenic extracts work through a completely different biological pathway. If you experience unexpected weight changes while on this treatment, it is likely due to other factors or medications, and you should discuss it with your primary care physician.
Vincetoxicum Hirundinaria Leaf can be taken alongside many common medications, but there are some critical exceptions. You must inform your doctor if you are taking beta-blockers or ACE inhibitors, as these can make allergic reactions more severe or harder to treat. Most daily allergy medications, like antihistamines or nasal sprays, are fine to continue during immunotherapy; in fact, they can help manage minor side effects. However, antihistamines must be stopped several days before a diagnostic skin test because they will block the reaction and lead to inaccurate results. Always provide your allergist with a full list of your current medications.
The concept of 'generic' drugs does not apply to allergenic extracts in the same way it does to chemical tablets. Because Vincetoxicum Hirundinaria Leaf is a 'Non-Standardized' extract, each manufacturer's version may have slight variations in protein composition. While different companies may produce an extract of the same plant, they are not considered interchangeable generics. Your allergist will typically stick with one manufacturer's product for the duration of your treatment to ensure consistency in your dosing. If a switch is necessary, your doctor will usually lower the dose temporarily to account for any differences in potency.